PHARMACOSMOS THERAPEUTICS INC. has sponsored the creation of one or more 401k plans.
Additional information about PHARMACOSMOS THERAPEUTICS INC.
Submission information for form 5500 for 401k plan PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN
| Measure | Date | Value |
|---|
| 2023 : PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN 2023 401k financial data |
|---|
| Transfers to/from the plan | 2023-12-31 | $0 |
| Total plan liabilities at end of year | 2023-12-31 | $0 |
| Total plan liabilities at beginning of year | 2023-12-31 | $0 |
| Total income from all sources | 2023-12-31 | $4,237,797 |
| Expenses. Total of all expenses incurred | 2023-12-31 | $934,283 |
| Benefits paid (including direct rollovers) | 2023-12-31 | $926,923 |
| Total plan assets at end of year | 2023-12-31 | $9,997,768 |
| Total plan assets at beginning of year | 2023-12-31 | $6,694,254 |
| Value of fidelity bond covering the plan | 2023-12-31 | $500,000 |
| Assets. Value of tangible personal property | 2023-12-31 | $0 |
| Total contributions received or receivable from participants | 2023-12-31 | $2,246,003 |
| Assets. Value of loans (other than to participants) | 2023-12-31 | $0 |
| Expenses. Other expenses not covered elsewhere | 2023-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2023-12-31 | $112,931 |
| Other income received | 2023-12-31 | $1,558,911 |
| Noncash contributions received | 2023-12-31 | $0 |
| Net income (gross income less expenses) | 2023-12-31 | $3,303,514 |
| Net plan assets at end of year (total assets less liabilities) | 2023-12-31 | $9,997,768 |
| Net plan assets at beginning of year (total assets less liabilities) | 2023-12-31 | $6,694,254 |
| Assets. Value of participant loans | 2023-12-31 | $155,259 |
| Assets. Value of assets in partnership/joint-venture interests | 2023-12-31 | $0 |
| Assets. Value of real-estate (other than employer real property) | 2023-12-31 | $0 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2023-12-31 | $0 |
| Assets. Value of employer securities | 2023-12-31 | $0 |
| Assets. Value of employer real property | 2023-12-31 | $0 |
| Total contributions received or receivable from employer(s) | 2023-12-31 | $319,952 |
| Value of certain deemed distributions of participant loans | 2023-12-31 | $0 |
| Value of corrective distributions | 2023-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2023-12-31 | $7,360 |
| 2022 : PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN 2022 401k financial data |
|---|
| Transfers to/from the plan | 2022-12-31 | $0 |
| Total plan liabilities at end of year | 2022-12-31 | $0 |
| Total plan liabilities at beginning of year | 2022-12-31 | $0 |
| Total income from all sources | 2022-12-31 | $1,942,417 |
| Expenses. Total of all expenses incurred | 2022-12-31 | $397,210 |
| Benefits paid (including direct rollovers) | 2022-12-31 | $395,682 |
| Total plan assets at end of year | 2022-12-31 | $6,694,254 |
| Total plan assets at beginning of year | 2022-12-31 | $5,149,047 |
| Value of fidelity bond covering the plan | 2022-12-31 | $500,000 |
| Total contributions received or receivable from participants | 2022-12-31 | $1,724,435 |
| Expenses. Other expenses not covered elsewhere | 2022-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2022-12-31 | $907,639 |
| Other income received | 2022-12-31 | $-1,132,080 |
| Noncash contributions received | 2022-12-31 | $0 |
| Net income (gross income less expenses) | 2022-12-31 | $1,545,207 |
| Net plan assets at end of year (total assets less liabilities) | 2022-12-31 | $6,694,254 |
| Net plan assets at beginning of year (total assets less liabilities) | 2022-12-31 | $5,149,047 |
| Assets. Value of participant loans | 2022-12-31 | $113,614 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2022-12-31 | $0 |
| Total contributions received or receivable from employer(s) | 2022-12-31 | $442,423 |
| Value of certain deemed distributions of participant loans | 2022-12-31 | $0 |
| Value of corrective distributions | 2022-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2022-12-31 | $1,528 |
| 2021 : PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN 2021 401k financial data |
|---|
| Transfers to/from the plan | 2021-12-31 | $0 |
| Total plan liabilities at end of year | 2021-12-31 | $0 |
| Total plan liabilities at beginning of year | 2021-12-31 | $0 |
| Total income from all sources | 2021-12-31 | $3,761,085 |
| Expenses. Total of all expenses incurred | 2021-12-31 | $595,178 |
| Benefits paid (including direct rollovers) | 2021-12-31 | $593,973 |
| Total plan assets at end of year | 2021-12-31 | $5,149,047 |
| Total plan assets at beginning of year | 2021-12-31 | $1,983,140 |
| Value of fidelity bond covering the plan | 2021-12-31 | $500,000 |
| Total contributions received or receivable from participants | 2021-12-31 | $1,600,006 |
| Expenses. Other expenses not covered elsewhere | 2021-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2021-12-31 | $1,228,094 |
| Other income received | 2021-12-31 | $500,707 |
| Noncash contributions received | 2021-12-31 | $0 |
| Net income (gross income less expenses) | 2021-12-31 | $3,165,907 |
| Net plan assets at end of year (total assets less liabilities) | 2021-12-31 | $5,149,047 |
| Net plan assets at beginning of year (total assets less liabilities) | 2021-12-31 | $1,983,140 |
| Assets. Value of participant loans | 2021-12-31 | $135,376 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2021-12-31 | $135,234 |
| Total contributions received or receivable from employer(s) | 2021-12-31 | $432,278 |
| Value of certain deemed distributions of participant loans | 2021-12-31 | $0 |
| Value of corrective distributions | 2021-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2021-12-31 | $1,205 |
| 2020 : PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN 2020 401k financial data |
|---|
| Transfers to/from the plan | 2020-12-31 | $0 |
| Total plan liabilities at end of year | 2020-12-31 | $0 |
| Total plan liabilities at beginning of year | 2020-12-31 | $0 |
| Total income from all sources | 2020-12-31 | $2,021,680 |
| Expenses. Total of all expenses incurred | 2020-12-31 | $38,540 |
| Benefits paid (including direct rollovers) | 2020-12-31 | $38,490 |
| Total plan assets at end of year | 2020-12-31 | $1,983,140 |
| Total plan assets at beginning of year | 2020-12-31 | $0 |
| Total contributions received or receivable from participants | 2020-12-31 | $517,745 |
| Expenses. Other expenses not covered elsewhere | 2020-12-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2020-12-31 | $1,114,556 |
| Other income received | 2020-12-31 | $251,589 |
| Noncash contributions received | 2020-12-31 | $0 |
| Net income (gross income less expenses) | 2020-12-31 | $1,983,140 |
| Net plan assets at end of year (total assets less liabilities) | 2020-12-31 | $1,983,140 |
| Net plan assets at beginning of year (total assets less liabilities) | 2020-12-31 | $0 |
| Assets. Value of participant loans | 2020-12-31 | $50,000 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2020-12-31 | $135,234 |
| Total contributions received or receivable from employer(s) | 2020-12-31 | $137,790 |
| Value of certain deemed distributions of participant loans | 2020-12-31 | $0 |
| Value of corrective distributions | 2020-12-31 | $0 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2020-12-31 | $50 |
| 2023: PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN 2023 form 5500 responses |
|---|
| 2023-01-01 | Type of plan entity | Single employer plan |
| 2023-01-01 | This submission is the final filing | No |
| 2023-01-01 | Plan is a collectively bargained plan | No |
| 2023-01-01 | Plan funding arrangement – Trust | Yes |
| 2023-01-01 | Plan benefit arrangement - Trust | Yes |
| 2022: PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN 2022 form 5500 responses |
|---|
| 2022-01-01 | Type of plan entity | Single employer plan |
| 2022-01-01 | This submission is the final filing | No |
| 2022-01-01 | Plan is a collectively bargained plan | No |
| 2022-01-01 | Plan funding arrangement – Trust | Yes |
| 2022-01-01 | Plan benefit arrangement - Trust | Yes |
| 2021: PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN 2021 form 5500 responses |
|---|
| 2021-01-01 | Type of plan entity | Single employer plan |
| 2021-01-01 | Submission has been amended | No |
| 2021-01-01 | This submission is the final filing | No |
| 2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2021-01-01 | Plan is a collectively bargained plan | No |
| 2021-01-01 | Plan funding arrangement – Trust | Yes |
| 2021-01-01 | Plan benefit arrangement - Trust | Yes |
| 2020: PHARMACOSMOS THERAPEUTICS RETIREMENT PLAN 2020 form 5500 responses |
|---|
| 2020-06-15 | Type of plan entity | Single employer plan |
| 2020-06-15 | First time form 5500 has been submitted | Yes |
| 2020-06-15 | Submission has been amended | No |
| 2020-06-15 | This submission is the final filing | No |
| 2020-06-15 | This return/report is a short plan year return/report (less than 12 months) | Yes |
| 2020-06-15 | Plan is a collectively bargained plan | No |
| 2020-06-15 | Plan funding arrangement – Trust | Yes |
| 2020-06-15 | Plan benefit arrangement - Trust | Yes |
